1.
Age-related upregulation of perineuronal nets on inferior collicular cells that project to the cochlear nucleus.Almassri LS, Ohl AP, Iafrate MC, Wade AD, Tokar NJ, Mafi AM, Beebe NL, Young JW, Mellott JG.Front Aging Neurosci. 2023 Nov 20;15:1271008. doi: 10.3389/fnagi.2023.1271008. eCollection 2023.PMID: 38053844 Free PMC article.

2.
Clinical application of bladder MRI and the Vesical Imaging-Reporting And Data System.Panebianco V, Briganti A, Boellaard TN, Catto J, Comperat E, Efstathiou J, van der Heijden AG, Giannarini G, Girometti R, Mertens L, Takeuchi M, Muglia VF, Narumi Y, Novara G, Pecoraro M, Roupret M, Sanguedolce F, Santini D, Shariat SF, Simone G, Vargas HA, Woo S, Barentsz J, Witjes JA.Nat Rev Urol. 2023 Nov 30. doi: 10.1038/s41585-023-00830-2. Online ahead of print.PMID: 38036666 Review.

3.
Outcomes of Cytoreductive Radical Prostatectomy for Oligometastatic Prostate Cancer on Prostate-specific Membrane Antigen Positron Emission Tomography: Results of a Multicenter European Study.Rajwa P, Robesti D, Chaloupka M, Zattoni F, Giesen A, Huebner NA, Krzywon A, Miszczyk M, Moll M, Stando R, Cisero E, Semko S, Checcucci E, Devos G, Apfelbeck M, Gatti C, Marra G, van den Bergh RCN, Goldner G, Rasul S, Ceci F, Dal Moro F, Porpiglia F, Gontero P, Bjartell A, Stief C, Heidenreich A, Joniau S, Briganti A, Shariat SF, Gandaglia G; EAU-Young Academic Urologists (YAU) Prostate Cancer Working Party.Eur Urol Oncol. 2023 Oct 14:S2588-9311(23)00197-9. doi: 10.1016/j.euo.2023.09.006. Online ahead of print.PMID: 37845121

4.
Outcomes of a Diagnostic Pathway for Prostate Cancer Based on Biparametric MRI and MRI-Targeted Biopsy Only in a Large Teaching Hospital.Paulino Pereira LJ, Reesink DJ, de Bruin P, Gandaglia G, van der Hoeven EJRJ, Marra G, Prinsen A, Rajwa P, Soeterik T, Kasivisvanathan V, Wever L, Zattoni F, van Melick HHE, van den Bergh RCN; EAU-YAU Prostate Cancer Working Group.Cancers (Basel). 2023 Sep 29;15(19):4800. doi: 10.3390/cancers15194800.PMID: 37835494 Free PMC article.

5.
Role of targeted biopsy, perilesional biopsy, random biopsy, and their combination in the detection of clinically significant prostate cancer by mpMRI/transrectal ultrasonography fusion biopsy in confirmatory biopsy during active surveillance program.Novara G, Zattoni F, Zecchini G, Aceti A, Pellizzari A, Ferraioli G, Cobacchini C, Taverna A, Sattin F, Carletti F, La Bombarda G, Lacognata CS, Lauro A, Gardiman M, Morlacco A, Betto G, Dal Moro F.Prostate Cancer Prostatic Dis. 2023 Oct 12. doi: 10.1038/s41391-023-00733-8. Online ahead of print.PMID: 37828151

6.
Perioperative and Functional Results for Robot-assisted Radical Cystectomy with Totally Intracorporeal Neobladder in Male Patients via the Vesica Patavina (Ves.Pa.) Technique: IDEAL Stage 2a Report.Dal Moro F, Zattoni F, Tonet E, Morlacco A, Betto G, Novara G.Eur Urol Open Sci. 2023 Sep 22;57:8-15. doi: 10.1016/j.euros.2023.09.001. eCollection 2023 Nov.PMID: 37771917 Free PMC article.

7.
The impact of a second MRI and re-biopsy in patients with initial negative mpMRI-targeted and systematic biopsy for PIRADS ≥ 3 lesions.Zattoni F, Pereira LJP, Marra G, Valerio M, Olivier J, Puche-Sanz I, Rajwa P, Maggi M, Campi R, Amparore D, De Cillis S, Junlong Z, Guo H, La Bombarda G, Fuschi A, Veccia A, Ditonno F, Marquis A, Barletta F, Leni R, Serni S, Kasivisvanathan V, Antonelli A, Dal Moro F, Rivas JG, van den Bergh RCN, Briganti A, Gandaglia G, Novara G.World J Urol. 2023 Nov;41(11):3357-3366. doi: 10.1007/s00345-023-04578-7. Epub 2023 Sep 27.PMID: 37755520 Free PMC article.

8.
How to preserve continence after radical prostatectomy: do not go straight, remember to curve!Dal Moro F.Minerva Urol Nephrol. 2023 Oct;75(5):548-551. doi: 10.23736/S2724-6051.23.05491-5.PMID: 37728491 No abstract available.

9.
Penile calciphylaxis, infrequent complication with bad prognosis: a case report.Ceccato T, Bruniera M, Iafrate M, Dal Moro F.Urol Case Rep. 2023 Jul 5;50:102476. doi: 10.1016/j.eucr.2023.102476. eCollection 2023 Sep.PMID: 37719180 Free PMC article.

10.
2023 WSES guidelines for the prevention, detection, and management of iatrogenic urinary tract injuries (IUTIs) during emergency digestive surgery.de’Angelis N, Schena CA, Marchegiani F, Reitano E, De Simone B, Wong GYM, Martínez-Pérez A, Abu-Zidan FM, Agnoletti V, Aisoni F, Ammendola M, Ansaloni L, Bala M, Biffl W, Ceccarelli G, Ceresoli M, Chiara O, Chiarugi M, Cimbanassi S, Coccolini F, Coimbra R, Di Saverio S, Diana M, Dioguardi Burgio M, Fraga G, Gavriilidis P, Gurrado A, Inchingolo R, Ingels A, Ivatury R, Kashuk JL, Khan J, Kirkpatrick AW, Kim FJ, Kluger Y, Lakkis Z, Leppäniemi A, Maier RV, Memeo R, Moore EE, Ordoñez CA, Peitzman AB, Pellino G, Picetti E, Pikoulis M, Pisano M, Podda M, Romeo O, Rosa F, Tan E, Ten Broek RP, Testini M, Tian Wei Cheng BA, Weber D, Sacco E, Sartelli M, Tonsi A, Dal Moro F, Catena F.World J Emerg Surg. 2023 Sep 9;18(1):45. doi: 10.1186/s13017-023-00513-8.PMID: 37689688 Free PMC article.

11.
Which Patients with Prostate Cancer and Lymph Node Uptake at Preoperative Prostate-specific Membrane Antigen Positron Emission Tomography/Computerized Tomography Scan Are at a Higher Risk of Prostate-specific Antigen Persistence After Radical Prostatectomy? Identifying Indicators of Systemic Disease by Integrating Clinical, Magnetic Resonance Imaging, and Functional Imaging Parameters.Mazzone E, Gandaglia G, Robesti D, Rajwa P, Gomez Rivas J, Ibáñez L, Soeterik TFW, Bianchi L, Afferi L, Kesch C, Darr C, Guo H, Zhuang J, Zattoni F, Fendler WP, Amparore D, Huebner NA, Giesen A, Joniau S, Schiavina R, Brunocilla E, Mattei A, Dal Moro F, Moreno Sierra J, Porpiglia F, Picchio M, Chiti A, van den Bergh R, Shariat SF, Montorsi F, Briganti A.Eur Urol Oncol. 2023 Sep 7:S2588-9311(23)00173-6. doi: 10.1016/j.euo.2023.08.010. Online ahead of print.PMID: 37689506

12.
Chronic Prostatitis/Chronic Pain Pelvic Syndrome and Male Infertility.Graziani A, Grande G, Martin M, Ferraioli G, Colonnello E, Iafrate M, Dal Moro F, Ferlin A.Life (Basel). 2023 Aug 7;13(8):1700. doi: 10.3390/life13081700.PMID: 37629557 Free PMC article. Review.

13.
Renal function assessment after embolization of vascular complications following partial nephrectomy.Novara G, Lami V, Evangelista L, Bartoletti P, De Conti G, Carletti F, Martino FK, Betto G, Zattoni F, Dal Moro F.BJU Int. 2023 Aug 22. doi: 10.1111/bju.16164. Online ahead of print.PMID: 37607303 No abstract available.

14.
Real-world Outcomes and Predictive Biomarkers for ¹⁷⁷Lutetium Prostate-specific Membrane Antigen Ligand Treatment in Metastatic Castration-resistant Prostate Cancer: A European Association of Urology Young Academic Urologists Prostate Cancer Working Group Multi-institutional Observational Study.Kafka M, Horninger A, di Santo G, Virgolini I, Neuwirt H, Unterrainer LM, Kunte SC, Deiss E, Paffenholz P, Heidenreich A, Rasul S, Einspieler H, Shariat SF, Rajwa P, Dozauer R, Tsaur I, Medlock E, Rölz N, Rausch S, la Fougère C, Trautwein N, Roesch MC, Merseburger AS, Zattoni F, Sepulcri M, Ladurner M, Bektic J, Gandaglia G, Horninger W, Heidegger I.Eur Urol Oncol. 2023 Aug 19:S2588-9311(23)00161-X. doi: 10.1016/j.euo.2023.07.018. Online ahead of print.PMID: 37604763

15.
Optimal combination therapy for metastatic hormone-sensitive prostate cancer: new evidence, challenges and unanswered questions.Zattoni F, Rajwa P, Gandaglia G; Young Academic Urologists Prostate Cancer Working Party (YAU-PCa WP).Curr Opin Urol. 2023 Nov 1;33(6):445-451. doi: 10.1097/MOU.0000000000001124. Epub 2023 Sep 11.PMID: 37603006 Free PMC article.

16.
Urology: a trip into metaverse.Randazzo G, Reitano G, Carletti F, Iafrate M, Betto G, Novara G, Dal Moro F, Zattoni F.World J Urol. 2023 Oct;41(10):2647-2657. doi: 10.1007/s00345-023-04560-3. Epub 2023 Aug 8.PMID: 37552265 Free PMC article. Review.

17.
Neutrophil-to-lymphocyte ratio as a prognostic factor for patients with urothelial carcinoma of the bladder following radical cystectomy.Zattoni F, Novara G, Iafrate M, Carletti F, Reitano G, Randazzo G, Ceccato T, Betto G, Dal Moro F.Cent European J Urol. 2023;76(2):90-103. doi: 10.5173/ceju.2023.039. Epub 2023 May 12.PMID: 37483852 Free PMC article.

18.
Bone health and body composition in transgender adults before gender-affirming hormonal therapy: data from the COMET study.Ceolin C, Scala A, Dall’Agnol M, Ziliotto C, Delbarba A, Facondo P, Citron A, Vescovi B, Pasqualini S, Giannini S, Camozzi V, Cappelli C, Bertocco A, De Rui M, Coin A, Sergi G, Ferlin A, Garolla A; Gender Incongruence Interdisciplinary Group (GIIG).J Endocrinol Invest. 2023 Jul 14. doi: 10.1007/s40618-023-02156-7. Online ahead of print.PMID: 37450195

19.
Sacrocolpopexy after sub-total hysterectomy vs. sacral hysteropexy for advanced urogenital prolapse: A propensity-matched study.Arcieri M, Morlacco A, Montebelli F, Mancini M, Soligo M, Restaino S, Driul L, Campagna G, Panico G, Ercoli A, Scambia G, Dal Moro F, Vizzielli G.Int J Gynaecol Obstet. 2023 Dec;163(3):847-853. doi: 10.1002/ijgo.14959. Epub 2023 Jun 29.PMID: 37382353

20.
European Association of Urology Biochemical Recurrence Risk Classification as a Decision Tool for Salvage Radiotherapy-A Multicenter Study.Preisser F, Abrams-Pompe RS, Stelwagen PJ, Böhmer D, Zattoni F, Magli A, Rivas JG, Dilme RV, Sepulcri M, Eguibar A, Heidegger I, Arnold C, Fankhauser CD, Chun FK, van der Poel H, Gandaglia G, Wiegel T, van den Bergh RCN, Tilki D; EAU-YAU Prostate Cancer Working Group.Eur Urol. 2023 Jun 22:S0302-2838(23)02886-5. doi: 10.1016/j.eururo.2023.05.038. Online ahead of print.PMID: 37355358

21.
Conditional survival does not improve over time in metastatic castration-resistant prostate cancer patients undergoing docetaxel.Modonutti D, Majdalany SE, Butaney M, Davis MJ, Corsi N, Sood A, Trinh QD, Cole AP, Rogers CG, Novara G, Abdollah F.Prostate. 2023 Sep;83(13):1238-1246. doi: 10.1002/pros.24583. Epub 2023 Jun 8.PMID: 37290911 Clinical Trial.

22.
Identification of the Optimal Candidates for Nodal Staging with Extended Pelvic Lymph Node Dissection Among Prostate Cancer Patients Who Underwent Preoperative Prostate-specific Membrane Antigen Positron Emission Tomography. External Validation of the Memorial Sloan Kettering Cancer Center and Briganti Nomograms and Development of a Novel Tool.Gandaglia G, Barletta F, Robesti D, Scuderi S, Rajwa P, Gomez Rivas J, Ibanez L, Soeterik TFW, Bianchi L, Afferi L, Kesch C, Darr C, Guo H, Zhuang J, Zattoni F, Fendler W, Marra G, Stabile A, Amparore D, Huebner NA, Giesen A, Joniau S, Schiavina R, Brunocilla E, Mattei A, Dal Moro F, Sierra JM, Porpiglia F, Picchio M, van den Bergh R, Shariat SF, Montorsi F, Briganti A.Eur Urol Oncol. 2023 Dec;6(6):543-552. doi: 10.1016/j.euo.2023.05.003. Epub 2023 Jun 1.PMID: 37270378

23.
Impact of Epithelial Histological Types, Subtypes, and Growth Patterns on Oncological Outcomes for Patients with Nonmetastatic Prostate Cancer Treated with Curative Intent: A Systematic Review.Marra G, van Leenders GJLH, Zattoni F, Kesch C, Rajwa P, Cornford P, van der Kwast T, van den Bergh RCN, Briers E, Van den Broeck T, De Meerleer G, De Santis M, Eberli D, Farolfi A, Gillessen S, Grivas N, Grummet JP, Henry AM, Lardas M, Lieuw M, Linares Espinós E, Mason MD, O’Hanlon S, van Oort IM, Oprea-Lager DE, Ploussard G, Rouvière O, Schoots IG, Stranne J, Tilki D, Wiegel T, Willemse PM, Mottet N, Gandaglia G; European Association of Urology Young Academic Urologists Prostate Cancer Working Group, the EAU-EANM-ESTRO-ESUR-ISUP-SIOG Guidelines Panel on Prostate Cancer.Eur Urol. 2023 Jul;84(1):65-85. doi: 10.1016/j.eururo.2023.03.014. Epub 2023 Apr 27.PMID: 37117107

24.
Role of targeted biopsy, perilesional biopsy, and random biopsy in prostate cancer diagnosis by mpMRI/transrectal ultrasonography fusion biopsy.Novara G, Zattoni F, Zecchini G, Aceti A, Pellizzari A, Ferraioli G, Carlesso M, La Bombarda G, Morlacco A, Lacognata CS, Lauro A, Gardiman M, Betto G, Zanovello N, Moro FD.World J Urol. 2023 Nov;41(11):3239-3247. doi: 10.1007/s00345-023-04382-3. Epub 2023 Apr 20.PMID: 37079076

25.
Role of radiomic analysis of [¹⁸F]fluoromethylcholine PET/CT in predicting biochemical recurrence in a cohort of intermediate and high risk prostate cancer patients at initial staging.Marturano F, Guglielmo P, Bettinelli A, Zattoni F, Novara G, Zorz A, Sepulcri M, Gregianin M, Paiusco M, Evangelista L.Eur Radiol. 2023 Oct;33(10):7199-7208. doi: 10.1007/s00330-023-09642-9. Epub 2023 Apr 20.PMID: 37079030 Free PMC article.

26.
Reply by Authors.Martini A, Wever L, Soeterik TFW, Rakauskas A, Fankhauser CD, Grogg JB, Checcucci E, Amparore D, Haiquel L, Rodriguez-Sanchez L, Ploussard G, Qiang P, Affentranger A, Marquis A, Marra G, Ettala O, Zattoni F, Falagario UG, De Angelis M, Kesch C, Apfelbeck M, Al-Hammouri T, Kretschmer A, Kasivisvanathan V, Preisser F, Lefebvre E, Olivier J, Radtke JP, Briganti A, Montorsi F, Carrieri G, Moro FD, Boström P, Jambor I, Gontero P, Chiu PK, John H, Macek P, Porpiglia F, Hermanns T, van den Bergh RCN, van Basten JA, Gandaglia G, Valerio M.J Urol. 2023 Jul;210(1):127. doi: 10.1097/JU.0000000000003442.02. Epub 2023 Apr 13.PMID: 37052482 No abstract available.

27.
Unilateral Pelvic Lymph Node Dissection in Prostate Cancer Patients Diagnosed in the Era of Magnetic Resonance Imaging-targeted Biopsy: A Study That Challenges the Dogma.Martini A, Wever L, Soeterik TFW, Rakauskas A, Fankhauser CD, Grogg JB, Checcucci E, Amparore D, Haiquel L, Rodriguez-Sanchez L, Ploussard G, Qiang P, Affentranger A, Marquis A, Marra G, Ettala O, Zattoni F, Falagario UG, De Angelis M, Kesch C, Apfelbeck M, Al-Hammouri T, Kretschmer A, Kasivisvanathan V, Preisser F, Lefebvre E, Olivier J, Radtke JP, Briganti A, Montorsi F, Carrieri G, Moro FD, Boström P, Jambor I, Gontero P, Chiu PK, John H, Macek P, Porpiglia F, Hermanns T, van den Bergh RCN, van Basten JA, Gandaglia G, Valerio M.J Urol. 2023 Jul;210(1):117-127. doi: 10.1097/JU.0000000000003442. Epub 2023 Apr 13.PMID: 37052480

28.
Magnetic resonance imaging (MRI) for local staging before salvage radical prostatectomy: a meta-analysis.Zapała P, Ślusarczyk A, Rajwa P, Gandaglia G, Zapała Ł, Zattoni F, Lorenc T, Ploussard G, Radziszewski P.World J Urol. 2023 May;41(5):1275-1284. doi: 10.1007/s00345-023-04383-2. Epub 2023 Apr 5.PMID: 37019997 Free PMC article. Review.

29.
Nadir creatinine as a predictor of renal outcomes in PUVs: A systematic review and meta-analysis.Meneghesso D, Bertazza Partigiani N, Spagnol R, Brazzale AR, Morlacco A, Vidal E.Front Pediatr. 2023 Mar 15;11:1085143. doi: 10.3389/fped.2023.1085143. eCollection 2023.PMID: 37009274 Free PMC article. Review.

30.
Experience in Multiparametric magnetic resonance prior to targeted prostate biopsy: the tip of the iceberg for cancer detection?Zattoni F, Maggi M, Giganti F, Gandaglia G; EAU-YAU Prostate Cancer Working Party.Minerva Urol Nephrol. 2023 Apr;75(2):254-257. doi: 10.23736/S2724-6051.23.05319-3.PMID: 36999843 No abstract available.

31.
Preliminary In Vitro Assessment of Decellularized Porcine Descending Aorta for Clinical Purposes.Casarin M, Fortunato TM, Imran SJ, Todesco M, Sandrin D, Marchesan M, Gerosa G, Romanato F, Bagno A, Dal Moro F, Morlacco A.J Funct Biomater. 2023 Mar 2;14(3):141. doi: 10.3390/jfb14030141.PMID: 36976065 Free PMC article.

32.
Correction: Surgeons’ perspectives on artificial intelligence to support clinical decision-making in trauma and emergency contexts: results from an international survey.Cobianchi L, Piccolo D, Dal Mas F, Agnoletti V, Ansaloni L, Balch J, Biffl W, Butturini G, Catena F, Coccolini F, Denicolai S, De Simone B, Frigerio I, Fugazzola P, Marseglia G, Marseglia GR, Martellucci J, Modenese M, Previtali P, Ruta F, Venturi A, Kaafarani HM, Loftus TJ; Team Dynamics Study Group.World J Emerg Surg. 2023 Mar 23;18(1):22. doi: 10.1186/s13017-023-00493-9.PMID: 36959605 Free PMC article. No abstract available.

33.
Abbreviated Versus Multiparametric Prostate MRI in Active Surveillance for Prostate-Cancer Patients: Comparison of Accuracy and Clinical Utility as a Decisional Tool.Zattoni F, Maresca S, Dal Moro F, Bednarova I, Randazzo G, Basso G, Reitano G, Giannarini G, Zuiani C, Girometti R.Diagnostics (Basel). 2023 Feb 4;13(4):578. doi: 10.3390/diagnostics13040578.PMID: 36832066 Free PMC article.

34.
Metastatic Sites’ Location and Impact on Patient Management After the Introduction of Prostate-specific Membrane Antigen Positron Emission Tomography in Newly Diagnosed and Biochemically Recurrent Prostate Cancer: A Critical Review.Mattana F, Muraglia L, Rajwa P, Zattoni F, Marra G, Chiu PKF, Heidegger I, Kasivisvanathan V, Kesch CV, Olivier J, Preisser F, Thibault C, Valerio M, van den Bergh RCN, Gandaglia G, Ceci F; European Association of Urology Young Academic Urologists Prostate Cancer Working Party.Eur Urol Oncol. 2023 Apr;6(2):128-136. doi: 10.1016/j.euo.2023.01.014. Epub 2023 Feb 16.PMID: 36804735 Review.

35.
Time for a paradigm shift in shared decision-making in trauma and emergency surgery? Results from an international survey.Cobianchi L, Dal Mas F, Agnoletti V, Ansaloni L, Biffl W, Butturini G, Campostrini S, Catena F, Denicolai S, Fugazzola P, Martellucci J, Massaro M, Previtali P, Ruta F, Venturi A, Woltz S, Kaafarani HM, Loftus TJ; Team Dynamics Study Group.World J Emerg Surg. 2023 Feb 17;18(1):14. doi: 10.1186/s13017-022-00464-6.PMID: 36803568 Free PMC article.

36.
Impact of preexisting opioid dependence on morbidity, length of stay, and inpatient cost of urological oncological surgery.Arora S, Bronkema C, Majdalany SE, Corsi N, Rakic I, Piontkowski A, Sood A, Davis MJ, Modonutti D, Novara G, Rogers CG, Abdollah F.World J Urol. 2023 Apr;41(4):1025-1031. doi: 10.1007/s00345-023-04306-1. Epub 2023 Feb 8.PMID: 36754878

37.
Is There an Impact of Transperineal Versus Transrectal Magnetic Resonance Imaging-targeted Biopsy on the Risk of Upgrading in Final Pathology in Prostate Cancer Patients Undergoing Radical Prostatectomy? An European Association of Urology-Young Academic Urologists Prostate Cancer Working Group Multi-institutional Study.Zattoni F, Marra G, Martini A, Kasivisvanathan V, Grummet J, Harkin T, Ploussard G, Olivier J, Chiu PK, Valerio M, Marquis A, Gontero P, Guo H, Zhuang J, Frydenberg M, Moon D, Morlacco A, Kretschmer A, Barletta F, Heidegger I, Tilki D, van den Bergh R, Dal Moro F, Briganti A, Montorsi F, Novara G, Gandaglia G; EAU-YAU Prostate Cancer Working Party.Eur Urol Focus. 2023 Jul;9(4):621-628. doi: 10.1016/j.euf.2023.01.016. Epub 2023 Feb 4.PMID: 36746729

38.
Cytoreductive Radical Prostatectomy for Metastatic Hormone-sensitive Prostate Cancer-Evidence from Recent Prospective Reports.Rajwa P, Zattoni F, Maggi M, Marra G, Kroyer P, Shariat SF, Briganti A, Montorsi F, Heidegger I, Gandaglia G; EAU-Young Academic Urologists (YAU) Prostate Cancer Working Party.Eur Urol Focus. 2023 Jul;9(4):637-641. doi: 10.1016/j.euf.2023.01.011. Epub 2023 Jan 23.PMID: 36697321 Review.

39.
Comment on: “Molecular biomarkers in the context of focal therapy for prostate cancer: recommendations of a Delphi Consensus from the Focal Therapy Society”.Rajwa P, Maggi M, Puche-Sanz I, Rempega G, Shariat SF, Zattoni F; EAU-Young Academic Urologists (YAU) Prostate Cancer Working Party.Minerva Urol Nephrol. 2022 Dec;74(6):816-818. doi: 10.23736/S2724-6051.22.05182-5.PMID: 36629815 No abstract available.

40.
The Changing Face of cN0M0 Prostate Cancer Being Found With pN+ After Surgery in the Contemporary Era: Results of an International European Survey on Disease Management.Sacco M, Gandaglia G, Aas K, Ceci F, Chiu P, Fankhauser CD, Fournier G, Heiddeger I, Kasivisvanathan V, Kesch C, Maggi M, Martini A, Olivier J, Ploussard G, Preisser F, Puche-Sanz I, Rajwa P, Soeterik T, Thibault C, Valerio M, van den Bergh RCN, Zattoni F, Rivas JG, Moschini M, Gillessen S, Bossi A, Gontero P, Marra G; YAU Prostate Cancer Working Group.Clin Genitourin Cancer. 2023 Jun;21(3):416.e1-416.e10. doi: 10.1016/j.clgc.2022.11.012. Epub 2022 Dec 5.PMID: 36609130

41.
Effect of Preoperative Multiparametric Magnetic Resonance Imaging on Oncologic and Functional Outcomes Following Radical Prostatectomy.Joyce DD, Soligo M, Morlacco A, Latuche LJR, Schulte PJ, Boorjian SA, Frank I, Gettman MT, Thompson RH, Tollefson MK, Karnes RJ.Eur Urol Open Sci. 2022 Dec 15;47:87-93. doi: 10.1016/j.euros.2022.11.018. eCollection 2023 Jan.PMID: 36601046 Free PMC article.

42.
Surgeons’ perspectives on artificial intelligence to support clinical decision-making in trauma and emergency contexts: results from an international survey.Cobianchi L, Piccolo D, Dal Mas F, Agnoletti V, Ansaloni L, Balch J, Biffl W, Butturini G, Catena F, Coccolini F, Denicolai S, De Simone B, Frigerio I, Fugazzola P, Marseglia G, Marseglia GR, Martellucci J, Modenese M, Previtali P, Ruta F, Venturi A, Kaafarani HM, Loftus TJ; Team Dynamics Study Group.World J Emerg Surg. 2023 Jan 3;18(1):1. doi: 10.1186/s13017-022-00467-3.PMID: 36597105 Free PMC article.

43.
Risk and predictors of adverse pathology after radical prostatectomy in patients diagnosed with IUSP 1-2 prostate cancer at MRI-targeted biopsy: a multicenter analysis.Kesch C, Pantea V, Soeterik T, Marquis A, la Bombarda G, Morlacco A, Barletta F, Radtke JP, Darr C, Preisser F, Zattoni F, Marra G, van den Bergh RCN, Hadaschik B, Gandaglia G; EAU-YAU Prostate Cancer Working Party.World J Urol. 2023 Feb;41(2):427-434. doi: 10.1007/s00345-022-04236-4. Epub 2022 Dec 19.PMID: 36534151 Free PMC article.

44.
A Novel Hybrid Membrane for Urinary Conduit Substitutes Based on Small Intestinal Submucosa Coupled with Two Synthetic Polymers.Casarin M, Todesco M, Sandrin D, Romanato F, Bagno A, Morlacco A, Dal Moro F.J Funct Biomater. 2022 Nov 5;13(4):222. doi: 10.3390/jfb13040222.PMID: 36412863 Free PMC article.

45.
In-hospital and 6-month outcomes in patients with COVID-19 supported with extracorporeal membrane oxygenation (EuroECMO-COVID): a multicentre, prospective observational study.Lorusso R, De Piero ME, Mariani S, Di Mauro M, Folliguet T, Taccone FS, Camporota L, Swol J, Wiedemann D, Belliato M, Broman LM, Vuylsteke A, Kassif Y, Scandroglio AM, Fanelli V, Gaudard P, Ledot S, Barker J, Boeken U, Maier S, Kersten A, Meyns B, Pozzi M, Pedersen FM, Schellongowski P, Kirali K, Barrett N, Riera J, Mueller T, Belohlavek J; EuroECMO-COVID Study Group.Lancet Respir Med. 2023 Feb;11(2):151-162. doi: 10.1016/S2213-2600(22)00403-9. Epub 2022 Nov 16.PMID: 36402148 Free PMC article.

46.
Diagnosis of clinically significant prostate cancer after negative multiparametric magnetic resonance imaging.Zattoni F, Morlacco A, Soligo M, Mancini M, Leone N, Zecchini G, Reitano G, Bednarova I, Lacognata CS, Lauro A, Zanovello N, Novara G, Dal Moro F.Cent European J Urol. 2022;75(3):277-283. doi: 10.5173/ceju.2022.0092. Epub 2022 Jul 22.PMID: 36381166 Free PMC article.

47.
Arterial Thrombotic Complications in COVID-19: A Case of Renal Infarction.Mancini M, Randazzo G, Piazza G, Dal Moro F.Biomedicines. 2022 Sep 21;10(10):2354. doi: 10.3390/biomedicines10102354.PMID: 36289613 Free PMC article.

48.
Association between age and efficacy of combination systemic therapies in patients with metastatic hormone-sensitive prostate cancer: a systematic review and meta-analysis.Rajwa P, Yanagisawa T, Heidegger I, Zattoni F, Marra G, Soeterik TFW, van den Bergh RCN, Valerio M, Ceci F, Kesch CV, Kasivisvanathan V, Laukhtina E, Kawada T, Nyiriadi P, Trinh QD, Chlosta P, Karakiewicz PI, Ploussard G, Briganti A, Montorsi F, Shariat SF, Gandaglia G; EAU-YAU Prostate Cancer Working Party.Prostate Cancer Prostatic Dis. 2023 Mar;26(1):170-179. doi: 10.1038/s41391-022-00607-5. Epub 2022 Oct 25.PMID: 36284192

49.
Changes in renal function after nephroureterectomy for upper urinary tract carcinoma: analysis of a large multicenter cohort (Radical Nephroureterectomy Outcomes (RaNeO) Research Consortium).Tafuri A, Marchioni M, Cerrato C, Mari A, Tellini R, Odorizzi K, Veccia A, Amparore D, Shakir A, Carbonara U, Panunzio A, Trovato F, Catellani M, Janello LMI, Bianchi L, Novara G, Dal Moro F, Schiavina R, De Lorenzis E, Parma P, Cimino S, De Cobelli O, Maiorino F, Bove P, Crocerossa F, Cantiello F, D’Andrea D, Di Cosmo F, Porpiglia F, Ditonno P, Montanari E, Soria F, Gontero P, Liguori G, Trombetta C, Mantica G, Borghesi M, Terrone C, Del Giudice F, Sciarra A, Galosi A, Moschini M, Shariat SF, Di Nicola M, Minervini A, Ferro M, Cerruto MA, Schips L, Pagliarulo V, Antonelli A.World J Urol. 2022 Nov;40(11):2771-2779. doi: 10.1007/s00345-022-04156-3. Epub 2022 Oct 6.PMID: 36203101 Free PMC article.

50.
Robotic partial nephrectomy for complex kidney cyst in a 4-year old boy: Points of technique.Barneschi AC, Betto G, Zanovello N, Rigamonti W, Bianco M, Morlacco A, Dal Moro F.J Pediatr Urol. 2022 Oct;18(5):710-711. doi: 10.1016/j.jpurol.2022.09.009. Epub 2022 Sep 14.PMID: 36171165

51.
von Hippel-Lindau disease integrated care pathway: Centralizing, expanding specialists’ theatre, and measuring improvement.Gardi M, Basso U, Ferrara AM, Zovato S, Feletti A, Watutantrige-Fernando S, Dal Moro F, Opocher G; VHL-Padova Network.Cancer. 2022 Nov 15;128(22):4027-4028. doi: 10.1002/cncr.34460. Epub 2022 Sep 28.PMID: 36169342 No abstract available.

52.
The Detection of Prostate Cancer with Magnetic Resonance Imaging-Targeted Prostate Biopsies is Superior with the Transperineal vs the Transrectal Approach. A European Association of Urology-Young Academic Urologists Prostate Cancer Working Group Multi-Institutional Study.Zattoni F, Marra G, Kasivisvanathan V, Grummet J, Nandurkar R, Ploussard G, Olivier J, Chiu PK, Valerio M, Gontero P, Guo H, Zhuang J, Barletta F, Leni R, Frydenberg M, Moon D, Hanegbi U, Landaumailto A, Snow R, Apfelbeck M, Kretschmer A, van den Bergh R, Novara G, Briganti A, Dal Moro F, Gandaglia G.J Urol. 2022 Oct;208(4):830-837. doi: 10.1097/JU.0000000000002802. Epub 2022 Sep 9.PMID: 36082555

53.
Transitional care in urology: the road to independence.Morlacco A, Bianco M, Dal Moro F.Nat Rev Urol. 2022 Dec;19(12):691-692. doi: 10.1038/s41585-022-00653-7.PMID: 36068352 No abstract available.

54.
A novel prognostic model predicting overall survival in patients with metastatic castration-resistant prostate cancer receiving standard chemotherapy: A multi-trial cohort analysis.Modonutti D, Majdalany SE, Corsi N, Li P, Sood A, Dalela D, Jamil ML, Hwang C, Menon M, Rogers CG, Trinh QD, Novara G, Abdollah F.Prostate. 2022 Sep;82(13):1293-1303. doi: 10.1002/pros.24403. Epub 2022 Jul 5.PMID: 35790016

55.
Tissue Engineering and Regenerative Medicine in Pediatric Urology: Urethral and Urinary Bladder Reconstruction.Casarin M, Morlacco A, Dal Moro F.Int J Mol Sci. 2022 Jun 7;23(12):6360. doi: 10.3390/ijms23126360.PMID: 35742803 Free PMC article. Review.

56.
Quality-of-Life Outcomes in Female Patients With Ileal Conduit or Orthotopic Neobladder Urinary Diversion: 6-Month Results of a Multicenter Prospective Study.Siracusano S, Zaka A, Bassi P, Gontero P, Mearini E, Imbimbo C, Simonato A, Dal Moro F, Giannarini G, Valotto C, Montorsi F, Colombo R, Porpiglia F, Bartoletti R, Vella M, Minervini A, Porcaro AB, Romantini F, Vicentini C, Talamini R, Ficarra V, Lonardi C.Front Oncol. 2022 Apr 12;12:855546. doi: 10.3389/fonc.2022.855546. eCollection 2022.PMID: 35515136 Free PMC article.

57.
Predictors of Unfavorable Pathology in Patients with Incidental (pT1a-T1b) Prostate Cancer.Tsaur I, van den Bergh RCN, Soeterik T, Thomas A, Brandt MP, Zattoni F, Dal Moro F, Morlacco A, Collavino J, Ploussard G, Surcel C, Mirvald C, Carmona O, Rosenzweig B, Ruckes C, Heisinger T, Heidegger I, Gandaglia G, Dotzauer R; European Association of Urology Young Academic Urologists Prostate Cancer Working Party.Eur Urol Focus. 2022 Nov;8(6):1599-1606. doi: 10.1016/j.euf.2022.03.009. Epub 2022 Mar 19.PMID: 35317972

58.
Role of Renin-Angiotensin System Blockers on BCG Response in Nonmuscle Invasive, High Risk Bladder Cancer.Motterle G, Morlacco A, Giovannini G, Vecchiato E, Iafrate M, Calpista A, Prayer-Galetti T, Martino F, Dal Moro F, Novara G.Clin Genitourin Cancer. 2022 Aug;20(4):e303-e309. doi: 10.1016/j.clgc.2022.02.007. Epub 2022 Feb 24.PMID: 35314138

59.
Crohn’s Disease-Related Stoma Complications and Their Impact on Postsurgical Course.Angriman I, Buzzi G, Giorato E, Barbierato M, Cavallin F, Ruffolo C, Degasperi S, Mari V, De Simoni O, Campi M, Zingales F, Roveron G, Iafrate M, Pucciarelli S, Bardini R, Scarpa M.Dig Surg. 2022;39(2-3):83-91. doi: 10.1159/000524036. Epub 2022 Mar 16.PMID: 35294945

60.
Identification of a gene signature for the prediction of recurrence and progression in non-muscle-invasive bladder cancer.Dalla E, Picco R, Novara G, Moro FD, Brancolini C.Mol Biomed. 2022 Mar 15;3(1):9. doi: 10.1186/s43556-022-00069-0.PMID: 35288800 Free PMC article. No abstract available.

61.
Biomarkers to personalize treatment with 177Lu-PSMA-617 in men with metastatic castration-resistant prostate cancer – a state of the art review.Heidegger I, Kesch C, Kretschmer A, Tsaur I, Ceci F, Valerio M, Tilki D, Marra G, Preisser F, Fankhauser CD, Zattoni F, Chiu P, Puche-Sanz I, Olivier J, van den Bergh RCN, Kasivisvanathan V, Pircher A, Virgolini I, Gandaglia G.Ther Adv Med Oncol. 2022 Mar 5;14:17588359221081922. doi: 10.1177/17588359221081922. eCollection 2022.PMID: 35273651 Free PMC article. Review.

62.
Porcine Small Intestinal Submucosa (SIS) as a Suitable Scaffold for the Creation of a Tissue-Engineered Urinary Conduit: Decellularization, Biomechanical and Biocompatibility Characterization Using New Approaches.Casarin M, Fortunato TM, Imran S, Todesco M, Sandrin D, Borile G, Toniolo I, Marchesan M, Gerosa G, Bagno A, Romanato F, Carniel EL, Morlacco A, Dal Moro F.Int J Mol Sci. 2022 Mar 4;23(5):2826. doi: 10.3390/ijms23052826.PMID: 35269969 Free PMC article.

63.
Metabolic syndrome and andrological diseases.Iafrate M, Ermacora C, Morlacco A, Dal Moro F, DI Vincenzo A, Rossato M.Panminerva Med. 2022 Sep;64(3):324-328. doi: 10.23736/S0031-0808.22.04628-6. Epub 2022 Feb 22.PMID: 35191634 Review.

64.
Optimal Dissemination of Scientific Manuscripts via Social Media: A Prospective Trial Comparing Visual Abstracts Versus Key Figures in Consecutive Original Manuscripts Published in European Urology.Klaassen Z, Vertosick E, Vickers AJ, Assel MJ, Novara G, Pierce C, Wallis CJD, Larcher A, Cooperberg MR, Catto JWF, Kutikov A.Eur Urol. 2022 Dec;82(6):633-636. doi: 10.1016/j.eururo.2022.01.041. Epub 2022 Feb 10.PMID: 35151514 Clinical Trial.

65.
Robotic ureteral reimplantation: systematic review and pooled analysis of comparative outcomes in adults.Carbonara U, Crocerossa F, Mehrazin R, Campi R, Marchioni M, Morlacco A, Paglairulo V, Wu Z, Autorino R, Stein RJ, Eun D, Ditonno P, Dal Moro F.Minerva Urol Nephrol. 2022 Apr;74(2):161-168. doi: 10.23736/S2724-6051.21.04558-4. Epub 2022 Feb 11.PMID: 35147383

66.
Successful Multidisciplinary Repair of Severe Bilateral Uretero-Enteric Stricture with Inflammatory Reaction Extending to the Left Iliac Artery, after Robotic Radical Cystectomy and Intracorporeal Ileal Neobladder.Mancini M, Nguyen AAL, Taverna A, Beltrami P, Zattoni F, Dal Moro F.Curr Oncol. 2021 Dec 29;29(1):155-162. doi: 10.3390/curroncol29010014.PMID: 35049688 Free PMC article.

67.
Assessment of Health-Related Quality of Life in Patients with Advanced Prostate Cancer-Current State and Future Perspectives.Kretschmer A, van den Bergh RCN, Martini A, Marra G, Valerio M, Tsaur I, Heidegger I, Kasivisvanathan V, Kesch C, Preisser F, Fankhauser CD, Zattoni F, Ceci F, Olivier J, Chiu P, Puche-Sanz I, Thibault C, Gandaglia G, Tilki D, On Behalf Of The Yau Prostate Cancer Working Group.Cancers (Basel). 2021 Dec 29;14(1):147. doi: 10.3390/cancers14010147.PMID: 35008310 Free PMC article. Review.

68.
Systematic Review of Active Surveillance for Clinically Localised Prostate Cancer to Develop Recommendations Regarding Inclusion of Intermediate-risk Disease, Biopsy Characteristics at Inclusion and Monitoring, and Surveillance Repeat Biopsy Strategy.Willemse PM, Davis NF, Grivas N, Zattoni F, Lardas M, Briers E, Cumberbatch MG, De Santis M, Dell’Oglio P, Donaldson JF, Fossati N, Gandaglia G, Gillessen S, Grummet JP, Henry AM, Liew M, MacLennan S, Mason MD, Moris L, Plass K, O’Hanlon S, Omar MI, Oprea-Lager DE, Pang KH, Paterson CC, Ploussard G, Rouvière O, Schoots IG, Tilki D, van den Bergh RCN, Van den Broeck T, van der Kwast TH, van der Poel HG, Wiegel T, Yuan CY, Cornford P, Mottet N, Lam TBL.Eur Urol. 2022 Apr;81(4):337-346. doi: 10.1016/j.eururo.2021.12.007. Epub 2021 Dec 31.PMID: 34980492

69.
Metabolic syndrome and urological diseases.Dal Moro F.Panminerva Med. 2022 Sep;64(3):314-315. doi: 10.23736/S0031-0808.21.04638-3. Epub 2021 Dec 21.PMID: 34931510 No abstract available.

70.
Features and management of men with pN1 cM0 prostate cancer after radical prostatectomy and lymphadenectomy: a systematic review of population-based evidence.Laine C, Gandaglia G, Valerio M, Heidegger I, Tsaur I, Olivier J, Ceci F, van den Bergh RCN, Kretschmer A, Thibault C, Chiu PK, Tilki D, Kasivisvanathan V, Preisser F, Zattoni F, Fankhauser C, Kesch C, Puche-Sanz I, Moschini M, Pradere B, Ploussard G, Marra G; EAU-YAU Prostate Cancer Working Party.Curr Opin Urol. 2022 Jan 1;32(1):69-84. doi: 10.1097/MOU.0000000000000946.PMID: 34812201

71.
The Impact of SARS-CoV-2 Pandemic on Time to Primary, Secondary Resection and Adjuvant Intravesical Therapy in Patients with High-Risk Non-Muscle Invasive Bladder Cancer: A Retrospective Multi-Institutional Cohort Analysis.Ferro M, Del Giudice F, Carrieri G, Busetto GM, Cormio L, Hurle R, Contieri R, Arcaniolo D, Sciarra A, Maggi M, Porpiglia F, Manfredi M, Fiori C, Antonelli A, Tafuri A, Bove P, Terrone C, Borghesi M, Costantini E, Iliano E, Montanari E, Boeri L, Russo GI, Madonia M, Tedde A, Veccia A, Simeone C, Liguori G, Trombetta C, Brunocilla E, Schiavina R, Dal Moro F, Racioppi M, Vartolomei MD, Longo N, Spirito L, Crocetto F, Cantiello F, Damiano R, Di Stasi SM, Marchioni M, Schips L, Parma P, Carmignani L, Conti A, Soria F, Gontero P, Barone B, Deho F, Zaffuto E, Papalia R, Scarpa RM, Pagliarulo V, Lucarelli G, Ditonno P, Botticelli FMG, Musi G, Catellani M, de Cobelli O.Cancers (Basel). 2021 Oct 21;13(21):5276. doi: 10.3390/cancers13215276.PMID: 34771440 Free PMC article.

72.
Has the COVID-19 outbreak changed the way we are treating prostate cancer? An EAU – YAU Prostate Cancer Working Group multi-institutional study.Zattoni F, Marra G, Kretschmer A, Preisser F, Tilki D, Kesch C, Radtke JP, Hoffmann N, Morlacco A, Dal Moro F, Soeterik TFW, van den Bergh RCN, Barletta F, Briganti A, Montorsi F, Gandaglia G.Cent European J Urol. 2021;74(3):362-365. doi: 10.5173/ceju.2021.0211. Epub 2021 Sep 18.PMID: 34729226 Free PMC article.

73.
Metabolic syndrome and stone disease.Soligo M, Morlacco A, Zattoni F, Valotto C, DE Giorgi G, Beltrami P.Panminerva Med. 2022 Sep;64(3):344-358. doi: 10.23736/S0031-0808.21.04517-1. Epub 2021 Oct 5.PMID: 34609121 Review.

74.
An Algorithm to Personalize Nerve Sparing in Men with Unilateral High-Risk Prostate Cancer.Martini A, Soeterik TFW, Haverdings H, Rahota RG, Checcucci E, De Cillis S, Hermanns T, Fankhauser CD, Afferi L, Moschini M, Mattei A, Kesch C, Heidegger I, Preisser F, Zattoni F, Marquis A, Marra G, Gontero P, Briganti A, Montorsi F, Porpiglia F, Van Basten JP, Van den Bergh RCN, Van Melick HHE, Ploussard G, Gandaglia G, Valerio M.J Urol. 2022 Feb;207(2):350-357. doi: 10.1097/JU.0000000000002205. Epub 2021 Sep 22.PMID: 34547922

75.
Metabolic syndrome and prostate cancer treatment.Morlacco A, Zattoni F, Soligo M, Lami V, Iafrate M, Zanovello N, Dal Moro F.Panminerva Med. 2022 Sep;64(3):359-364. doi: 10.23736/S0031-0808.21.04511-0. Epub 2021 Sep 6.PMID: 34486368 Review.

76.
Patients with renal transplant and moderate-to-severe LUTS benefit from urodynamic evaluation and early transurethral resection of the prostate.Righetto M, Mancini M, Modonutti D, Calpista A, Beltrami P, Dal Moro F.World J Urol. 2021 Dec;39(12):4397-4404. doi: 10.1007/s00345-021-03799-y. Epub 2021 Sep 4.PMID: 34480590 Free PMC article.

77.
Detection rate of 18F-Choline positron emission tomography/computed tomography in patients with non-metastatic hormone sensitive and castrate resistant prostate cancer.Zattoni F, Artioli P, Burei M, Chiaravalloti A, Chierichetti F, Donner D, Panareo S, Rambaldi I, Schillaci O, Dal Moro F, Evangelista L.Q J Nucl Med Mol Imaging. 2023 Jun;67(2):167-173. doi: 10.23736/S1824-4785.21.03366-5. Epub 2021 Sep 3.PMID: 34477346

78.
A real-world comparison of docetaxel versus abiraterone acetate for metastatic hormone-sensitive prostate cancer.Tsaur I, Heidegger I, Bektic J, Kafka M, van den Bergh RCN, Hunting JCB, Thomas A, Brandt MP, Höfner T, Debedde E, Thibault C, Ermacora P, Zattoni F, Foti S, Kretschmer A, Ploussard G, Rodler S, von Amsberg G, Tilki D, Surcel C, Rosenzweig B, Gadot M, Gandaglia G, Dotzauer R; EAU-YAU Prostate Cancer Working Party.Cancer Med. 2021 Sep;10(18):6354-6364. doi: 10.1002/cam4.4184. Epub 2021 Aug 10.PMID: 34374489 Free PMC article.

79.
High-intensity local treatment of clinical node-positive urothelial carcinoma of the bladder alongside systemic chemotherapy improves overall survival.Sood A, Keeley J, Palma-Zamora I, Novara G, Elshaikh M, Jeong W, Hensley P, Navai N, Peabody JO, Trinh QD, Rogers CG, Menon M, Abdollah F.Urol Oncol. 2022 Feb;40(2):62.e1-62.e11. doi: 10.1016/j.urolonc.2021.07.018. Epub 2021 Aug 2.PMID: 34348860

80.
Focal Therapy for Prostate Cancer: Complications and Their Treatment.Rakauskas A, Marra G, Heidegger I, Kasivisvanathan V, Kretschmer A, Zattoni F, Preisser F, Tilki D, Tsaur I, van den Bergh R, Kesch C, Ceci F, Fankhauser C, Gandaglia G, Valerio M.Front Surg. 2021 Jul 12;8:696242. doi: 10.3389/fsurg.2021.696242. eCollection 2021.PMID: 34322516 Free PMC article. Review.

81.
Radiation Therapy After Radical Prostatectomy: What Has Changed Over Time?Zattoni F, Heidegger I, Kasivisvanathan V, Kretschmer A, Marra G, Magli A, Preisser F, Tilki D, Tsaur I, Valerio M, van den Bergh R, Kesch C, Ceci F, Fankhauser C, Gandaglia G.Front Surg. 2021 Jul 9;8:691473. doi: 10.3389/fsurg.2021.691473. eCollection 2021.PMID: 34307443 Free PMC article. Review.

82.
The European Urology Commitment to Gender Equity and Diversity: Expanding Cognitive Diversity through Inclusivity at the Podium.Psutka SP, Morgan T, Albersen M, Cornu JN, Novara G, Plimack E, Ost P, Catto JWF.Eur Urol. 2021 Oct;80(4):450-453. doi: 10.1016/j.eururo.2021.07.002. Epub 2021 Jul 17.PMID: 34284917 No abstract available.

83.
Renal Tumor Size and Presence of Synchronous Lung Metastasis at Time of Diagnosis: Implications for Chest Imaging.Jamil M, Hanna R, Sood A, Corsi N, Modonutti D, Keeley J, Etta P, Novara G, Patel A, Rogers C, Abdollah F.Urology. 2021 Dec;158:110-116. doi: 10.1016/j.urology.2021.04.070. Epub 2021 Jul 17.PMID: 34284011

84.
Impact of Lymphovascular Invasion on Overall Survival in Patients With Prostate Cancer Following Radical Prostatectomy: Stage-per-Stage Analysis.Jamil M, Rakic N, Sood A, Keeley J, Modonutti D, Novara G, Jeong W, Menon M, Rogers CG, Abdollah F.Clin Genitourin Cancer. 2021 Oct;19(5):e319-e325. doi: 10.1016/j.clgc.2021.04.009. Epub 2021 Apr 20.PMID: 34154946

85.
Validation of the plasmid study to relate DNA damaging effects of radionuclides to those from external beam radiotherapy.Verger E, Cheng J, de Santis V, Iafrate M, Jackson JA, Imberti C, Fruhwirth GO, Blower PJ, Ma MT, Burnham DR, Terry SYA.Nucl Med Biol. 2021 Sep-Oct;100-101:36-43. doi: 10.1016/j.nucmedbio.2021.06.004. Epub 2021 Jun 15.PMID: 34153932 Free PMC article.

86.
Risks and Benefits of Live Surgical Broadcast: A Systematic Review.Carbonara U, Crocerossa F, Novara G, Ditonno P, Pansadoro V, Breda A, Rocco B, Cacciamani GE, Lamb AD, Kaouk J, Porpiglia F, Autorino R.Eur Urol Focus. 2022 May;8(3):870-881. doi: 10.1016/j.euf.2021.06.003. Epub 2021 Jun 18.PMID: 34148861 Review.

87.
Radical Prostatectomy: Sequelae in the Course of Time.Kesch C, Heidegger I, Kasivisvanathan V, Kretschmer A, Marra G, Preisser F, Tilki D, Tsaur I, Valerio M, van den Bergh RCN, Fankhauser CD, Zattoni F, Gandaglia G.Front Surg. 2021 May 28;8:684088. doi: 10.3389/fsurg.2021.684088. eCollection 2021.PMID: 34124138 Free PMC article. Review.

88.
Domestic trauma with penile and scrotum skin degloving and testicular avulsion.Iafrate M, Leone N, Mancini M, Prayer T, Bassetto F, Moro FD.J Surg Case Rep. 2021 May 26;2021(5):rjab175. doi: 10.1093/jscr/rjab175. eCollection 2021 May.PMID: 34055285 Free PMC article.

89.
Comparison of MRI, PET, and 18F-choline PET/MRI in patients with oligometastatic recurrent prostate cancer.Evangelista L, Cassarino G, Lauro A, Morlacco A, Sepulcri M, Nguyen AAL, Ietto F, Cecchin D, Lacognata C, Zucchetta P.Abdom Radiol (NY). 2021 Sep;46(9):4401-4409. doi: 10.1007/s00261-021-03131-7. Epub 2021 May 28.PMID: 34047801 Free PMC article.

90.
Digital rectal examination and prostate biopsy at the time of COVID-19 outbreak: are there risks of contamination for the urologist?Bartoletti R, Pilatz A, Ficarra V, Tubaro A, Mogorovich A, Novara G.Minerva Urol Nephrol. 2021 Apr;73(2):268-269. doi: 10.23736/S2724-6051.21.04270-3.PMID: 34036767 No abstract available.

91.
Urology practice during the COVID-19 vaccination campaign.Ficarra V, Novara G, Giannarini G, De Nunzio C, Abrate A, Bartoletti R, Crestani A, Esperto F, Galfano A, Gregori A, Liguori G, Pavan N, Simonato A, Trombetta C, Tubaro A, Porpiglia F, Scarpa RM, Mirone V.Urologia. 2021 Nov;88(4):298-305. doi: 10.1177/03915603211016321. Epub 2021 May 13.PMID: 33983086 Free PMC article.

92.
Patient- and Tumour-related Prognostic Factors for Urinary Incontinence After Radical Prostatectomy for Nonmetastatic Prostate Cancer: A Systematic Review and Meta-analysis.Lardas M, Grivas N, Debray TPA, Zattoni F, Berridge C, Cumberbatch M, Van den Broeck T, Briers E, De Santis M, Farolfi A, Fossati N, Gandaglia G, Gillessen S, O’Hanlon S, Henry A, Liew M, Mason M, Moris L, Oprea-Lager D, Ploussard G, Rouviere O, Schoots IG, van der Kwast T, van der Poel H, Wiegel T, Willemse PP, Yuan CY, Grummet JP, Tilki D, van den Bergh RCN, Lam TB, Cornford P, Mottet N.Eur Urol Focus. 2022 May;8(3):674-689. doi: 10.1016/j.euf.2021.04.020. Epub 2021 May 6.PMID: 33967010 Review.

93.
Analysis of the Clinical and Epidemiological Meaning of Screening Test for SARS-CoV-2: Considerations in the Chronic Kidney Disease Patients during the COVID-19 Pandemic.Martino F, Amici G, Grandesso S, Ferraro Mortellaro R, Lo Cicero A, Novara G.J Clin Med. 2021 Mar 9;10(5):1139. doi: 10.3390/jcm10051139.PMID: 33803083 Free PMC article. Review.

94.
Nomograms in Urologic Oncology: Lights and Shadows.Morlacco A, Modonutti D, Motterle G, Martino F, Dal Moro F, Novara G.J Clin Med. 2021 Mar 2;10(5):980. doi: 10.3390/jcm10050980.PMID: 33801184 Free PMC article. Review.

95.
Anaesthesiologist: The ‘Best Man’ for the Robotic Patient.Valotto C, Dal Moro F.Malays J Med Sci. 2021 Feb;28(1):120-121. doi: 10.21315/mjms2021.28.1.16. Epub 2021 Feb 24.PMID: 33679229 Free PMC article. No abstract available.

96.
A retrospective multicentric analysis on testicular torsion: is there still something to learn?Leone N, Morlacco A, D’Elia C, Amodeo A, Vecchio D, Tiscione D, Zeccolini G, Ferraioli G, Frazza LA, Bettin L, Congregalli A, Migliozzi F, Liguori G, Trombetta C, Dal Moro F, Iafrate M.Scand J Urol. 2021 Oct;55(5):408-411. doi: 10.1080/21681805.2021.1889026. Epub 2021 Feb 23.PMID: 33620015

97.
Evaluation of lymphovascular invasion as a prognostic predictor of overall survival after radical prostatectomy.Rakic N, Jamil M, Keeley J, Sood A, Vetterlein M, Dalela D, Arora S, Modonutti D, Bronkema C, Novara G, Peabody J, Rogers C, Menon M, Abdollah F.Urol Oncol. 2021 Aug;39(8):495.e1-495.e6. doi: 10.1016/j.urolonc.2021.01.007. Epub 2021 Feb 16.PMID: 33602620

98.
What People Search for When Browsing “Doctor Google.” An Analysis of Search Trends in Italy after the Law on Pain.Miceli L, Bednarova R, Bednarova I, Rizzardo A, Cobianchi L, Dal Mas F, Biancuzzi H, Bove T, Dal Moro F, Zattoni F.J Pain Palliat Care Pharmacother. 2021 Mar;35(1):23-30. doi: 10.1080/15360288.2021.1882640. Epub 2021 Feb 12.PMID: 33577371

99.
Radical prostatectomy technique in the robotic evolution: from da Vinci standard to single port-a single surgeon pathway.Francavilla S, Veccia A, Dobbs RW, Zattoni F, Vigneswaran HT, Antonelli A, Dal Moro F, Autorino R, Simeone C, Crivellaro S.J Robot Surg. 2022 Feb;16(1):21-27. doi: 10.1007/s11701-021-01194-8. Epub 2021 Feb 7.PMID: 33554284 Free PMC article.

100.
Incidence and Treatment of Incarcerated Trocar-Site Hernias After Robotic Surgery: Presentation of Three Cases.Mancini M, Righetto M, Dal Moro F, Zattoni F.J Endourol Case Rep. 2020 Dec 29;6(4):271-274. doi: 10.1089/cren.2020.0110. eCollection 2020.PMID: 33457652 Free PMC article.

101.
Gadolinium-Based Contrast Media Nephrotoxicity in Kidney Impairment: The Physio-Pathological Conditions for the Perfect Murder.Martino F, Amici G, Rosner M, Ronco C, Novara G.J Clin Med. 2021 Jan 13;10(2):271. doi: 10.3390/jcm10020271.PMID: 33450989 Free PMC article. Review.

102.
Oncological outcomes of salvage radical prostatectomy for recurrent prostate cancer in the contemporary era: A multicenter retrospective study.Marra G, Karnes RJ, Calleris G, Oderda M, Alessio P, Palazzetti A, Battaglia A, Pisano F, Munegato S, Munoz F, Filippini C, Ricardi U, Linares E, Sanchez-Salas R, Goonewardene S, Dasgupta P, Challacombe B, Popert R, Cahill D, Gillatt D, Persad R, Palou J, Joniau S, Smelzo S, Piechaud T, Taille A, Roupret M, Albisinni S, van Velthoven R, Morlacco A, Vidit S, Gandaglia G, Mottrie A, Smith J, Joshi S, Fiscus G, Berger A, Aron M, Abreu A, Gill IS, Van Der Poel H, Tilki D, Murphy D, Lawrentschuk N, Davis J, Gontero P.Urol Oncol. 2021 May;39(5):296.e21-296.e29. doi: 10.1016/j.urolonc.2020.11.002. Epub 2021 Jan 10.PMID: 33436329

103.
Outcome and quality of life of patients with augmented bladder or urinary diversion after kidney transplantation.Pozza G, Iafrate M, Mancini M, Silvestre C, Neri F, Furian L, Rigotti P, Prayer Galetti T.Arch Ital Urol Androl. 2020 Dec 17;92(4). doi: 10.4081/aiua.2020.4.286.PMID: 33348954

104.
How Can the COVID-19 Pandemic Lead to Positive Changes in Urology Residency?Busetto GM, Del Giudice F, Mari A, Sperduti I, Longo N, Antonelli A, Cerruto MA, Costantini E, Carini M, Minervini A, Rocco B, Artibani W, Porreca A, Porpiglia F, Damiano R, De Sio M, Arcaniolo D, Cimino S, Russo GI, Lucarelli G, Di Tonno P, Gontero P, Soria F, Trombetta C, Liguori G, Scarpa RM, Papalia R, Terrone C, Borghesi M, Verze P, Madonia M, De Lisa A, Bove P, Guazzoni G, Lughezzani G, Racioppi M, Di Gianfrancesco L, Brunocilla E, Schiavina R, Simeone C, Veccia A, Montorsi F, Briganti A, Dal Moro F, Pavone C, Serretta V, Di Stasi SM, Galosi AB, Schips L, Marchioni M, Montanari E, Carrieri G, Cormio L, Greco F, Musi G, Maggi M, Conti SL, Tubaro A, De Berardinis E, Sciarra A, Gallucci M, Mirone V, de Cobelli O, Ferro M.Front Surg. 2020 Nov 24;7:563006. doi: 10.3389/fsurg.2020.563006. eCollection 2020.PMID: 33330604 Free PMC article.

105.
Spermatic Cord Sarcoma: A 20-Year Single-Institution Experience.Iafrate M, Motterle G, Zaborra C, Leone N, Prayer-Galetti T, Zattoni F, Guttilla A, Cappellesso R, Dei Tos AP, Rossi CR, Del Fiore P, Rastrelli M, Mocellin S.Front Surg. 2020 Nov 17;7:566408. doi: 10.3389/fsurg.2020.566408. eCollection 2020.PMID: 33282904 Free PMC article.

106.
Comment on “Proving the Effectiveness of the Fundamentals of Robotic Surgery (FRS) Skills Curriculum: A Single-blinded, Multispecialty, Multi-institutional Randomized Control Trial”: Not Only Surgeon’s Manual Skills….Valotto C, Dal Moro F.Ann Surg. 2021 Dec 1;274(6):e846-e847. doi: 10.1097/SLA.0000000000004663.PMID: 33278168 No abstract available.

107.
The impact of COVID-19 pandemic on pornography habits: a global analysis of Google Trends.Zattoni F, Gül M, Soligo M, Morlacco A, Motterle G, Collavino J, Barneschi AC, Moschini M, Moro FD.Int J Impot Res. 2020 Dec;33(8):824-831. doi: 10.1038/s41443-020-00380-w. Epub 2020 Nov 28.PMID: 33249423 Free PMC article.

108.
Relative position of bladder neck to pubic symphysis on cystogram is a strong and reproducible predictor of early urinary continence recovery following radical prostatectomy.Rossanese M, Caloggero S, Alario G, Mucciardi G, Novara G, Giannarini G, Ficarra V.Urologia. 2021 May;88(2):115-121. doi: 10.1177/0391560320974891. Epub 2020 Nov 24.PMID: 33234060

109.
Computed tomography features predicting aggressiveness of malignant parenchymal renal tumors suitable for partial nephrectomy.Ficarra V, Caloggero S, Rossanese M, Giannarini G, Crestani A, Ascenti G, Novara G, Porpiglia F.Minerva Urol Nephrol. 2021 Feb;73(1):17-31. doi: 10.23736/S2724-6051.20.04073-4. Epub 2020 Nov 17.PMID: 33200903 Review.

110.
The role of multiparametric MRI in active surveillance for low-risk prostate cancer: The ROMAS randomized controlled trial.Schiavina R, Droghetti M, Novara G, Bianchi L, Gaudiano C, Panebianco V, Borghesi M, Piazza P, Mineo Bianchi F, Guerra M, Corcioni B, Fiorentino M, Giunchi F, Verze P, Pultrone C, Golfieri R, Porreca A, Mirone V, Brunocilla E.Urol Oncol. 2021 Jul;39(7):433.e1-433.e7. doi: 10.1016/j.urolonc.2020.10.018. Epub 2020 Nov 13.PMID: 33191117 Clinical Trial.

111.
Prognostic Stratification of Bladder Cancer Patients with a MicroRNA-based Approach.Cavallari I, Grassi A, Del Bianco P, Aceti A, Zaborra C, Sharova E, Bertazzolo I, D’Agostino DM, Iafrate M, Ciminale V.Cancers (Basel). 2020 Oct 26;12(11):3133. doi: 10.3390/cancers12113133.PMID: 33114775 Free PMC article.

112.
Comparison of multiple abbreviated multiparametric MRI-derived protocols for the detection of clinically significant prostate cancer.Cereser L, Giannarini G, Bonato F, Pizzolitto S, Como G, Valotto C, Ficarra V, Dal Moro F, Zuiani C, Girometti R.Minerva Urol Nephrol. 2022 Feb;74(1):29-37. doi: 10.23736/S2724-6051.20.03952-1. Epub 2020 Oct 5.PMID: 33016030

113.
Measuring the Quality of Diagnostic Prostate Magnetic Resonance Imaging: A Urologist’s Perspective.Giannarini G, Valotto C, Girometti R, Dal Moro F, Briganti A, Padhani AR.Eur Urol. 2021 Apr;79(4):440-441. doi: 10.1016/j.eururo.2020.09.015. Epub 2020 Sep 18.PMID: 32951929

114.
Detection Rate of Prostate Specific Membrane Antigen Tracers for Positron Emission Tomography/Computerized Tomography in Prostate Cancer Biochemical Recurrence: A Systematic Review and Network Meta-Analysis.Crocerossa F, Marchioni M, Novara G, Carbonara U, Ferro M, Russo GI, Porpiglia F, Di Nicola M, Damiano R, Autorino R, Cantiello F.J Urol. 2021 Feb;205(2):356-369. doi: 10.1097/JU.0000000000001369. Epub 2020 Sep 16.PMID: 32935652

115.
PET/MRI in prostate cancer: a systematic review and meta-analysis.Evangelista L, Zattoni F, Cassarino G, Artioli P, Cecchin D, Dal Moro F, Zucchetta P.Eur J Nucl Med Mol Imaging. 2021 Mar;48(3):859-873. doi: 10.1007/s00259-020-05025-0. Epub 2020 Sep 8.PMID: 32901351 Free PMC article. Review.

116.
A Contemporary Case Series of Complex Surgical Repair of Surgical/Endoscopic Injuries to the Abdominal Ureter.Ficarra V, Rossanese M, Crestani A, Caloggero S, Alario G, Novara G, Giannarini G, Valotto C.Eur Urol Focus. 2021 Nov;7(6):1476-1484. doi: 10.1016/j.euf.2020.07.003. Epub 2020 Aug 16.PMID: 32814683

117.
Successful Treatment of Vesicovaginal Fistulas via an Abdominal Transvesical Approach: A Single-center 50-yr Experience.Mancini M, Righetto M, Modonutti D, Morlacco A, Dal Moro F, Zattoni F; European Reference Network for Rare Urogenital Diseases Complex Conditions (ERN eUROGEN).Eur Urol Focus. 2021 Nov;7(6):1485-1492. doi: 10.1016/j.euf.2020.06.017. Epub 2020 Jul 31.PMID: 32747296

118.
The war against the SARS-CoV2 infection: Is it better to fight or mitigate it?Dal Moro F, Vendramin I, Livi U.Med Hypotheses. 2020 Oct;143:110129. doi: 10.1016/j.mehy.2020.110129. Epub 2020 Jul 22.PMID: 32721814 Free PMC article.

119.
Accuracy of abbreviated multiparametric MRI-derived protocols in predicting local staging of prostate cancer in men undergoing radical prostatectomy.Giannarini G, Cereser L, Como G, Bonato F, Pizzolitto S, Valotto C, Ficarra V, Dal Moro F, Zuiani C, Girometti R.Acta Radiol. 2021 Jul;62(7):949-958. doi: 10.1177/0284185120943047. Epub 2020 Jul 27.PMID: 32718179

120.
Edges-On-Dartos: An Easy Way to Improve Graft Performance in Staged Hypospadias Repair.Morlacco A, Gobbi D, Esposito C, Castagnetti M.Urology. 2020 Oct;144:245-248. doi: 10.1016/j.urology.2020.07.011. Epub 2020 Jul 22.PMID: 32711013

121.
Are we always sure that “less is more”?Dal Moro F.J Robot Surg. 2020 Dec;14(6):923-924. doi: 10.1007/s11701-020-01123-1. Epub 2020 Jul 20.PMID: 32691354 No abstract available.

122.
Re: Michael S. Hofman, Nathan Lawrentschuk, Roslyn J. Francis, et al. Prostate-specific Membrane Antigen PET-CT in Patients with High-risk Cancer Before Curative-intent Surgery or Radiotherapy (proPSMA): A Prospective, Randomized, Multicenter Study. Lancet 2020;395:1208-16.Evangelista L, De Salvo GL, Zattoni F, Novara G.Eur Urol Oncol. 2020 Oct;3(5):713. doi: 10.1016/j.euo.2020.06.013. Epub 2020 Jul 18.PMID: 32690404 No abstract available.

123.
Relevance of the Endoscopic Evaluation in the Diagnosis of Bladder Pain Syndrome/Interstitial Cystitis.Morlacco A, Mancini M, Soligo M, Zattoni F, Calpista A, Vizzielli G, Patti R, Mandato FG, Barneschi AC, Zattoni F, Iafrate M, Dal Moro F; European Reference Network for rare UROGENital disease and complex conditions (ERN eUROGEN).Urology. 2020 Oct;144:106-110. doi: 10.1016/j.urology.2020.06.032. Epub 2020 Jun 30.PMID: 32619597

124.
Telehealth in Urology: A Systematic Review of the Literature. How Much Can Telemedicine Be Useful During and After the COVID-19 Pandemic?Novara G, Checcucci E, Crestani A, Abrate A, Esperto F, Pavan N, De Nunzio C, Galfano A, Giannarini G, Gregori A, Liguori G, Bartoletti R, Porpiglia F, Scarpa RM, Simonato A, Trombetta C, Tubaro A, Ficarra V; Research Urology Network (RUN).Eur Urol. 2020 Dec;78(6):786-811. doi: 10.1016/j.eururo.2020.06.025. Epub 2020 Jun 18.PMID: 32616405 Free PMC article.

125.
The Impact of Centralised Services on Metric Reflecting High-quality Performance: Outcomes from 1110 Consecutive Radical Cystectomies at a Single Centre.Pang KH, Thomas F, Novara G, Din OS, Morgan SL, Hussain SA, Jubber I, Noon AP, Catto JWF, Rosario DJ.Eur Urol Focus. 2021 May;7(3):554-565. doi: 10.1016/j.euf.2020.05.011. Epub 2020 Jun 21.PMID: 32576531

126.
An International Survey on the Use of Thromboprophylaxis in Urological Surgery.Violette PD, Vernooij RWM, Aoki Y, Agarwal A, Cartwright R, Arai Y, Tailly T, Novara G, Baldeh T, Craigie S, Breau RH, Guyatt GH, Tikkinen KAO.Eur Urol Focus. 2021 May;7(3):653-658. doi: 10.1016/j.euf.2020.05.015. Epub 2020 Jun 16.PMID: 32561453

127.
Minimally invasive urologic surgery is safe during COVID-19: experience from two high-volume centers in Italy.Motterle G, Dal Moro F, Zanovello N, Morlacco A, Boemo DG, Zattoni F, Zattoni F.J Robot Surg. 2020 Dec;14(6):909-911. doi: 10.1007/s11701-020-01099-y. Epub 2020 Jun 15.PMID: 32542448 Free PMC article.

128.
Morbidity, mortality, and quality assessment following open radical cystectomy in elderly patients with bladder cancer.Prayer Galetti T, Soligo M, Morlacco A, Lami V, Nguyen AAL, Iafrate M, Zattoni F.Aging Clin Exp Res. 2021 Apr;33(4):1049-1061. doi: 10.1007/s40520-020-01613-0. Epub 2020 Jun 13.PMID: 32535856

129.
The impact of COVID-19 pandemic on urological emergencies: a single-center experience.Motterle G, Morlacco A, Iafrate M, Bianco M, Federa G, Xhafka O, Zattoni F, Prayer-Galetti T.World J Urol. 2021 Jun;39(6):1985-1989. doi: 10.1007/s00345-020-03264-2. Epub 2020 May 23.PMID: 32447443 Free PMC article.

130.

Re: Giorgio Ivan Russo, Carmen Scandura, Marina Di Mauro, et al. Clinical Efficacy of Serenoa repens Versus Placebo Versus Alpha-blockers for the Treatment of Lower Urinary Tract Symptoms/Benign Prostatic Enlargement: A Systematic Review and Network Meta-analysis of Randomized Placebo-controlled Clinical Trials. Eur Urol Focus. In press. https://doi.org/10.1016/j.euf.2020.01.002: New Evidence Changing Clinical Practice or Misunderstanding of Statistical Analyses? The Case of Serenoa repens and α-Blockers.De Nunzio C, Novara G, Damiano R, Bartoletti R, Tubaro A, Ficarra V; members of the Research Urological Network.Eur Urol Focus. 2021 Jul;7(4):894-896. doi: 10.1016/j.euf.2020.03.011. Epub 2020 May 14.PMID: 32418876 No abstract available.

131.

Outcomes of Salvage Radical Prostatectomy for M0 Castration-resistant Recurrent Prostate Cancer: A Reasonable Option in the Era of New Antiandrogen Therapies?Marra G, Calleris G, Alessio P, Oderda M, Palou J, Joniau S, Piechaud T, Smelzo S, Morlacco A, Sharma V, Tilki D, Van der Poel H, Veerman H, Karnes RJ, Gontero P.Eur Urol Focus. 2021 Jul;7(4):807-811. doi: 10.1016/j.euf.2020.04.005. Epub 2020 May 12.PMID: 32414618

132.

How to manage a partial detachment of the ureter during robotic radical prostatectomy?
Dal Moro F, Goffo F, Ferraioli G, Zaborra C, Valotto C.
Minerva Urol Nephrol. 2021 Oct;73(5):672-673. doi: 10.23736/S2724-6051.19.03628-2. Epub 2020 Jan 29.
PMID: 32003206